Abstract:BACKGROUND: The polycystic ovary syndrome (PCOS) is possibly the most common endocrine disorder in premenopausal women, with prevalences in the 6-7% range reported worldwide. Although PCOS is primarily a disorder of androgen excess, affected women frequently present with abdominal adiposity and insulin resistance, explaining the association of PCOS with metabolic comorbidities and an increased cardiovascular risk. Abdominal adiposity, and very especially the compensatory hyperinsulinism resulting from insulin resistance, further contribute to hyperandrogenism. These pathophysiological mechanisms must be considered when deciding the optimal therapy for PCOS patients.OBJECTIVE: To review the impact of the current approaches to the treatment of PCOS on the metabolic associations and the cardiovascular risk of these women.METHODS: Review of published studies addressing the effects of different treatment strategies of PCOS.RESULTS: The resolution of PCOS after the marked and sustained weight loss attained after bariatric surgery makes this therapeutic option a first-line strategy in women presenting with severe obesity. In patients with lesser grades of obesity who desire fertility, a short trial of metformin, followed by classic ovulation induction and/or assisted reproductive techniques in case pregnancy is not achieved in a few months, is a reasonable approach. If fertility is not an immediate concern, third generation oral contraceptive pills containing a neutral or antiandrogenic progestin remains the drug of choice, considering their efficacy, their excellent tolerability, and their overall metabolic safety.CONCLUSION: Strategies targeting obesity and abdominal adiposity, insulin resistance and hyperandrogenism, alone or in combination, are effective in ameliorating the signs and symptoms of hyperandrogenism while improving the metabolic comorbidities and the cardiovascular risk of these patients in most cases.

Polycystic Ovary Syndrome and Oxidative Stress. Natural Treatments

Polycystic ovary syndrome and its management: In view of oxidative stress

Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review

Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives

Polycystic ovary syndrome: treatment strategies and management

Could polyphenols be an effective treatment in the management of polycystic ovary syndrome?

Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome

Evaluation of Oxytocin Level and Its Relationship With Oxidant-Antioxidant Status in Women With Polycystic Ovarian Syndrome

Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.

Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights

Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome

Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome

[The effects of oxidative stress to PCOS]

The interplay between oxidative stress, zinc, and metabolic dysfunction in polycystic ovarian syndrome

Relationship between Serum Levels of Oxidative Stress Markers and Metabolic Syndrome Components in PCOS Women

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome

Exploring the Antioxidative Effects of Ginger and Cinnamon: A Comprehensive Review of Evidence and Molecular Mechanisms Involved in Polycystic Ovary Syndrome (PCOS) and Other Oxidative Stress-Related Disorders

Role of Oxidative Stress in Obese and Nonobese PCOS Patients

Current treatment for polycystic ovary syndrome: focus on adolescence

Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature

The physiological basis of complementary and alternative medicines for polycystic ovary syndrome